US Patent

US11395856 — Lipid-encapsulated gas microsphere compositions and related methods

Method of Use · Assigned to Lantheus Medical Imaging Inc · Expires 2035-12-28 · 10y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects improved lipid formulations used to generate lipid-encapsulated gas microspheres and methods of their use.

USPTO Abstract

The invention provides, inter alia, improved lipid formulations used to generate lipid-encapsulated gas microspheres, and methods of their use.

Drugs covered by this patent

perflutren (PERFLUTREN)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-665`	—	perflutren

Patent Metadata

Patent number: US11395856
Jurisdiction: US
Classification: Method of Use
Expires: 2035-12-28
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Lantheus Medical Imaging Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.